[Insert Logo]

Journal of Osteopathic Medicine June 2024: Comorbidities associated with symptoms of subjective cognitive decline in individuals aged 45–64

OVERVIEW:

Early-stage cognitive decline occurs when an individual experiences memory loss or other cognitive impairment but does not meet the criteria for Alzheimer’s disease (AD) or other dementias. After diagnosis of mild cognitive impairment (MCI), approximately 5 to 15% of cases progress to dementia per year. AD and many other causes of dementia are presently incurable. Early recognition of cognitive decline can allow healthcare providers to reduce the risk of disease progression. Literature is scarce on factors that can increase the incidence of cognitive decline, especially in early ages; this is further exacerbated by difficulty tracking the prevalence of mild cognitive symptoms. This analysis aims to determine demographic and comorbid factors that predispose individuals to higher rates of early-stage subjective cognitive impairment in order to determine which individuals should be screened at earlier stages.

Authors: Zach Monahan; Jacob Heath; Alexis Ditren Santos; Alicia Ford, PhD; Micah Hartwell, PhD

OBJECTIVES:

 Describe the epidemiology and impact of mild cognitive impairment

 Discuss the comorbid factors associated with subjective cognitive decline

 Explain potential treatments to improve cognition in individuals with and without comorbid factors

Expiration Date:  June 4, 2027

The AOA designates this activity for a maximum of 1.0 AOA Category 1-B Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.